Worldwide One-year Open-label Safety Study of Flibanserin in Women With HSDD.
Phase of Trial: Phase III
Latest Information Update: 20 Dec 2015
At a glance
- Drugs Flibanserin (Primary)
- Indications Decreased libido; Female sexual dysfunction
- Focus Adverse reactions; Registrational
- Acronyms SUNFLOWER
- Sponsors Boehringer Ingelheim
- 20 Dec 2015 Results published in the Annals of Pharmacotherapy
- 20 Dec 2015 According to the pooled results published in Annals of Pharmacotherapy, this trial is an extension study of BEGONIA trial (a multicentre, double blinded, placebo controlled, 24-week trial conducted in North America).
- 12 Jun 2014 Status changed from completed to discontinued,as reported by ClinicalTrials.gov.